Christopher R. Cline, CHIEF FINANCIAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 10,384 shares at $20.12 ($209K) on 2025-02-03, disclosed to the SEC on 2025-02-04.
Open-market sale of $209k TVTX by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.12 | 5,192 | $104K | 50.0% |
| 2 | $20.12 | 5,192 | $104K | 50.0% |
| Total | $20.12 avg | 10,384 | $209K | 100% |
| Filing → |
| TVTX | SELL | 2026-05-06 | $115K | — | Filing → |
| TVTX | SELL | 2026-04-15 | $349K | — | Filing → |
| TVTX | SELL | 2026-02-05 | $56K | — | Filing → |